Stolt-Nielsen Limited (SNI)
Oslo Børs · Norway · prices in NOK · close of 27 Oct 2026
Key indicators
| Last close | NOK 345.00 |
|---|---|
| 52-week range | 281.50 – 375.00 |
| Return, 1 month / 3 months | −3.6% / +9.5% |
| Return, 1 year / 3 years | +12.2% / +20.3% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 47 |
| Volatility (1 year) | 31.3% |
| Worst drawdown (1 year) | -18.2% |
| Average daily value traded | 12.64M NOK |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Stolt-Nielsen Limited is a shipping and logistics company based in Norway that specialises in the transport and storage of bulk liquid chemicals and other liquids. Its main activities include operating a fleet of chemical tankers, providing tank containers for door-to-door movement of liquids, and running terminal and tank storage facilities. Customers are mainly chemical producers, traders and industrial users who need safe handling of specialised liquid cargoes across international trade routes.
Stolt-Nielsen Limited trades under the code SNI on the Oslo Børs in Norway, with its price quoted in Norwegian kroner (NOK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Stolt-Nielsen Limited (SNI) trades on the Oslo Børs in Norway. It last closed at NOK 345.00 on 27 October 2026.
Its price-based Market X-Ray is 72 out of 100 (a strong price profile), ranking 43 of 294 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 12.2% and over the last three months it rose 9.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Oslo Børs
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 74 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 8.3% | ||
| From 52-week high | -7.8% | ||
| Momentum | 71 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 9.5% | ||
| 6-month return | 17.7% | ||
| 12-month return, skipping the last month | 16.4% | ||
| Stability (higher is calmer) | 70 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 31.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.2% | ||
| Liquidity | 76 · Strong | Trades actively. | |
| Average daily value traded | 12.64M NOK | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −1.0% |
|---|---|
| 1 month | −3.6% |
| 3 months | +9.5% |
| 6 months | +17.7% |
| 1 year | +12.2% |
| 3 years | +20.3% |
| 5 years | +280.5% |
Signals
| 50-day / 200-day average | 346.13 / 318.68 |
|---|---|
| Golden / death cross (60 days) | Golden, 44 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 10.90 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 21 Apr 2026 | USD 9.3186 |
| 19 Nov 2025 | USD 10.1231 |
| 23 Apr 2025 | USD 12.9130 |
| 21 Nov 2024 | USD 13.8409 |
| 24 Apr 2024 | USD 16.3962 |
| 22 Nov 2023 | USD 10.6574 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Oslo Børs; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.